Overview Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma Status: Completed Trial end date: 2012-10-01 Target enrollment: Participant gender: Summary The purpose of this study was to collect information regarding the safety and tolerability of mifamurtide (liposomal muramyl tripeptide phosphatidyl ethanolamine; L-MTP-PE). Details Lead Sponsor: Millennium Pharmaceuticals, Inc.Treatments: Acetylmuramyl-Alanyl-IsoglutamineMifamurtide